Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Taipei Exchange - Delayed Quote TWD

Hantech Bio-Technology Co., Ltd. (1294.TWO)

86.00
+0.80
+(0.94%)
At close: April 30 at 1:30:33 PM GMT+8
Currency in TWD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
748,423
748,423
625,141
302,518
240,294
Cost of Revenue
442,680
442,680
344,289
175,885
139,266
Gross Profit
305,743
305,743
280,852
126,633
101,028
Operating Expense
108,301
108,301
95,708
69,193
62,409
Operating Income
197,442
197,442
185,144
57,440
38,619
Net Non Operating Interest Income Expense
-3,987
-3,987
-1,462
-1,203
-1,503
Pretax Income
194,641
194,641
184,569
57,728
38,418
Tax Provision
39,222
39,222
37,036
11,869
7,333
Net Income Common Stockholders
155,674
155,674
148,118
47,473
32,558
Diluted NI Available to Com Stockholders
155,674
155,674
148,118
47,473
32,558
Basic EPS
6.02
--
5.90
2.05
1.55
Diluted EPS
5.86
--
5.76
2.00
1.48
Basic Average Shares
25,859.47
--
25,104.75
23,199.80
20,967.38
Diluted Average Shares
26,565.53
--
25,714.93
23,710.70
21,958.56
Total Expenses
550,981
550,981
439,997
245,078
201,675
Net Income from Continuing & Discontinued Operation
155,674
155,674
148,118
47,473
32,558
Normalized Income
155,653.24
155,653.24
147,668.77
47,953.61
31,705.18
Interest Income
1,389
1,389
654
267
46
Interest Expense
5,376
5,376
2,116
1,470
1,549
Net Interest Income
-3,987
-3,987
-1,462
-1,203
-1,503
EBIT
200,017
200,017
186,685
59,198
39,967
EBITDA
232,090
232,090
207,631
78,523
58,668
Reconciled Cost of Revenue
442,680
442,680
344,289
175,885
139,266
Reconciled Depreciation
32,073
32,073
20,946
19,325
18,701
Net Income from Continuing Operation Net Minority Interest
155,674
155,674
148,118
47,473
32,558
Total Unusual Items Excluding Goodwill
26
26
562
-605
1,054
Total Unusual Items
26
26
562
-605
1,054
Normalized EBITDA
232,064
232,064
207,069
79,128
57,614
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
5.24
5.24
112.77
-124.39
201.18
12/31/2021 - 9/30/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers